Umedica Laboratories Private Limited Praziquantel Export Data — India (DGFT 2022–2026)

Name: Umedica Laboratories Private Limited Praziquantel Export Records India — #12 Exporter, 4 Shipments, $50.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Praziquantel

India Pharmaceutical Trade Intelligence

$2.9M148 Suppliers80 CountriesHS 30049099

ExportsIndia → PHILIPPINES32.0%India → MOZAMBIQUE7.4%

ImportsFRANCE → India$32.9M GERMANY → India$1.7M

#1 Supplier: LOB INTERNATIONAL

Umedica Laboratories Private Limited — Praziquantel Exporter #12 | $50.1K Trade Value | TransData Nexus | TransData Nexus

Umedica Laboratories Private Limited — Praziquantel Exporter Profile

Indian Pharmaceutical Exporter · #12 for Praziquantel · $50.1K export value · DGFT Verified

Umedica Laboratories Private Limited is the #12 Indian exporter of Praziquantel with $50.1K in export value and 4 verified shipments. Umedica Laboratories Private Limited holds a 1.7% market share in Praziquantel exports across 2 countries. The company exports 11 pharmaceutical products worth $32.2M across 8 therapeutic categories.

Umedica Laboratories Private Limited — Praziquantel Export Profile: Buyers & Destinations

Umedica Laboratories Private Limited Praziquantel export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Praziquantel?

Country	Value	Shipments	Share
PHILIPPINES	$550.0K	11	27.6%
MOZAMBIQUE	$215.7K	33	10.8%
NIGERIA	$203.8K	12	10.2%
UNITED STATES	$199.8K	10

Who Are the Top Buyers of Praziquantel from India?

Buyer	Country	Value	Orders
KHRIZ PHARMA TRADING INC	PHILIPPINES	$350.0K	7
WHO CAMEROON	CAMEROON	$129.6K	3
M/S,GREAT TIMEC PHARMA CO, LTD,	NIGERIA	$110.2K	4
ENDURE MEDICAL, INC.	PHILIPPINES	$100.0K	2
SEPROS LIMITED	KENYA	$69.2K	12
AFRI FARMACIA LDA	MOZAMBIQUE	$59.1K	6
NEGADRAS GENERAL TRADING COMPANY PL	ETHIOPIA	$53.5K	3
MEDECINS SANS FRONTIERES LOGISTIQUE	FRANCE	$44.6K	2
AFRI PHARMACIA LDA	MOZAMBIQUE	$41.8K	2
ZINOM INTERNACIONAL LDA	ANGOLA	$40.2K	2

India's Praziquantel is purchased by 200 buyers worldwide. The top buyer is KHRIZ PHARMA TRADING INC (PHILIPPINES), followed by WHO CAMEROON and M/S,GREAT TIMEC PHARMA CO, LTD,.

How Does Umedica Laboratories Private Limited Compare to Nearest Praziquantel Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
10	CIARA PHARMACEUTICALS	$59.1K	6	1	$9.9K
11	MACLEODS PHARMACEUTICALS LIMITED	$53.5K	3	1	$17.8K
12	UMEDICA LABORATORIES PRIVATE LIMITED ★	$50.1K	4	2	$12.5K

Umedica Laboratories Private Limited ranks #12 among 148 Indian Praziquantel exporters. Average shipment value of $12.5K compared to the market average of $9.5K. The closest competitors by value are CIARA PHARMACEUTICALS and MACLEODS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Praziquantel Exports?

Port	Shipments	% Share
SAHAR AIR	164	28.1%
SAHAR AIR CARGO ACC (INBOM4)	97	16.6%
Bombay Air	41	7.0%
NHAVA SHEVA SEA (INNSA1)	34	5.8%
Bombay Air Cargo	30	5.1%
JNPT/ NHAVA SHEVA SEA	20	3.4%
DELHI AIR	19	3.3%
DELHI AIR CARGO ACC (INDEL4)	18	3.1%

Geopolitical & Trade Policy Impact on Umedica Laboratories Private Limited's Praziquantel Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Umedica Laboratories. The Israel-Iran conflict has led to disruptions in Middle East trade routes, particularly affecting the Red Sea shipping lanes. Major shipping lines have imposed 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, effectively increasing the cost of exporting goods through these routes. This escalation in shipping costs can erode profit margins and necessitate strategic adjustments in logistics and pricing strategies. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian goods by the US, including a 25% tariff announced in 2025, poses a significant challenge. This tariff could lead to increased costs for Indian pharmaceutical products in the US market, potentially affecting demand and profitability. (en.wikipedia.org)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a promising avenue for Umedica. The FTA eliminates tariffs on Indian pharmaceutical exports to the EU, providing a competitive advantage and facilitating market expansion. This agreement is expected to open a market worth $572.3 billion for Indian pharmaceutical and MedTech exports to Europe from 2027 onward. (mordorintelligence.com)

Umedica Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have stringent Good Manufacturing Practice (GMP) requirements. Historically, non-compliance has led to import bans and reputational damage for Indian firms. For instance, in 2013, the FDA banned imports from certain Indian pharmaceutical companies due to GMP violations, highlighting the critical importance of adherence to quality standards. (comcec.org)

While specific regulatory events concerning Umedica Laboratories are not detailed in the available data, the company's sustained export performance suggests a commitment to maintaining high-quality standards and compliance with international regulations. Continuous investment in quality control systems and regulatory compliance is essential to navigate the evolving landscape and to capitalize on global market opportunities.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Praziquantel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Umedica Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 80+ countries, 200+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Praziquantel

Praziquantel

Umedica Laboratories Private Limited — Praziquantel Exporter Profile

Umedica Laboratories Private Limited — Praziquantel Export Profile: Buyers & Destinations

Where Does India Export Praziquantel?

Who Are the Top Buyers of Praziquantel from India?

What Is India's Total Praziquantel Export Value and How Much Does Umedica Laboratories Private Limited Contribute?

What Is the Average Shipment Value for Umedica Laboratories Private Limited's Praziquantel Exports?

How Does Umedica Laboratories Private Limited Compare to Other Indian Praziquantel Exporters?

Regulatory Requirements: Exporting Praziquantel to Key Markets

Nigeria — NAFDAC

United States — FDA

How Does Umedica Laboratories Private Limited Compare to Nearest Praziquantel Exporters?

Which Indian Ports Ship Praziquantel Exports?

Geopolitical & Trade Policy Impact on Umedica Laboratories Private Limited's Praziquantel Exports

Umedica Laboratories Private Limited — Regulatory Compliance & Quality Standards

About Umedica Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Praziquantel Export Data from Umedica Laboratories Private Limited

Praziquantel Stats

Company Overview

Top Products by Umedica Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source